| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. | 10%+ Owner | Common Stock | 1.66M | $91.7M | $55.27 | May 11, 2023 | Indirect |
| Zenas BioPharma, Inc. | 10%+ Owner | Common Stock | 1.92M | $36.4M | $19.00 | Oct 9, 2025 | Indirect |
| eFFECTOR Therapeutics, Inc. | 10%+ Owner | Common Stock | 1.82M | $1.1M | $0.61 | Nov 27, 2023 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Oct 9, 2025 | 2 | $2.4M | 4 | Oct 14, 2025 | 10%+ Owner |
| ZBIO | Zenas BioPharma, Inc. | Sep 16, 2024 | 9 | $38M | 4 | Sep 16, 2024 | 10%+ Owner |
| ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | 10%+ Owner |
| EFTR | eFFECTOR Therapeutics, Inc. | Nov 27, 2023 | 2 | -$369K | 4 | Nov 29, 2023 | 10%+ Owner |
| ACLX | Arcellx, Inc. | May 11, 2023 | 4 | -$45.6M | 4 | May 15, 2023 | 10%+ Owner |
| ACLX | Arcellx, Inc. | Feb 8, 2022 | 12 | $25M | 4 | Feb 10, 2022 | 10%+ Owner |
| ACLX | Arcellx, Inc. | Feb 3, 2022 | 0 | $0 | 3 | Feb 3, 2022 | 10%+ Owner |
| EFTR | eFFECTOR Therapeutics, Inc. | Aug 25, 2021 | 0 | $0 | 3 | Sep 2, 2021 | 10%+ Owner |